MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE TO COCAINE SELF-ADMINISTRATION 

Release Date:  April 27, 1999  

RFP AVAILABLE:  N01DA-9-8096

P.T.

National Institute on Drug Abuse

Under the upcoming solicitation, The National Institute on Drug Abuse (NIDA)
is soliciting proposals from qualified organizations having the in-house
capability to perform in vivo rodent behavioral pharmacology studies of
potential pharmacotherapies for cocaine dependence using a cocaine self-administration reinstatement model.  The Contractor will be blinded to the
identity of proprietary test compounds, the compounds will be evaluated in
established assays, and the resulting data will be utilized by the NIDA
Medications Development Division.  The successful offeror must indicate
possession of current DEA registration for Schedules II-V substances prior to
award and apply for Schedule I registration.  NIDA anticipates awarding a
four-year contract with optional quantities.  RFP No. N01DA-9-8096 will be
available electronically on or about May 6, 1999, and may be accessed through
the Internet at the following address: (URL:
http://www.nida.nih.gov/RFP/RFPList.html).  All information required for the
submission of an offer will be contained in the electronic RFP package.
Response to the RFP will be due on or about June 21, 1999.  Any responsible
offeror may submit a proposal that will be considered by the Government.  This
advertisement does not commit the Government to award a contract. 

INQUIRIES
 
Point of Contact:

Patricia W. Mummaugh, Contract Specialist 
Electronic Mail Address: pm69j@nih.gov  
Telephone: (301) 443-6677
FAX: (301) 443-7595

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.